NATURAL HEALTH TRENDS CORP Just Filed Its Quarterly Report: Net Income (Loss) Pe...

Net Income (Loss) Per Common Share


 


Diluted net income (loss) per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. The dilutive effect of non-vested restricted stock is reflected by application of the treasury stock method. Under the treasury stock method, the amount of compensation cost for future service that the Company has not yet recognized, if any, is assumed to be used to repurchase shares.


 


The following tables illustrate the computation of basic and diluted net income (loss) per common share for the periods indicated (in thousands, except per share data):


 












  

Three Months Ended June 30,

 
  

2020

  

2019

 
  

Income (Numerator)

  

Shares (Denominator)

  

Per Share Amount

  

Income (Numerator)

  

Shares (Denominator)

  

Per Share Amount

 

Basic net income per common share:

                        

Net income available to common stockholders

 $34   10,580  $0.00  $397   11,082  $0.04 

Effect of dilutive securities:

                        

Non-vested restricted stock

     844          53     

Diluted net income per common share:

                        

Net income available to common stockholders plus assumed conversions

 $34   11,424  $0.00  $397   11,135  $0.04 


 












  

Six Months Ended June 30,

 
  

2020

  

2019

 
  

Loss (Numerator)

  

Shares (Denominator)

  

Per Share Amount

  

Loss (Numerator)

  

Shares (Denominator)

  

Per Share Amount

 

Basic net loss per common share:

                        

Net loss available to common stockholders

 $(539)  10,532  $(0.05) $(1,526)  11,207  $(0.14)

Effect of dilutive securities:

                        

Non-vested restricted stock

                    

Diluted net loss per common share:

                        

Net loss available to common stockholders plus assumed conversions

 $(539)  10,532  $(0.05) $(1,526)  11,207  $(0.14)


 


In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents because their inclusion would be anti-dilutive. As such, non-vested restricted stock totaling 892,083 and 55,430 shares were not included for the six-month periods ended June 30, 2020 and 2019, respectively.


 

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever NATURAL HEALTH TRENDS CORP makes a similar move, sign up!

Auto Refresh

Feedback